𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase II study of tiazofurin in gliomas in adults

✍ Scribed by David J. Stewart; Elizabeth Eisenhauer; David R. Macdonald; J. Gregory Cairncross; Adrian Langleben

Publisher
Springer US
Year
1993
Tongue
English
Weight
328 KB
Volume
15
Category
Article
ISSN
0167-594X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Effect of HECNU in malignant supratentor
Effect of HECNU in malignant supratentorial gliomas β€” a phase II study
✍ P. Georges; S. Przedborski; J. Brotchi; M. Chatel; D. GΓ©douin; J. Hildebrand πŸ“‚ Article πŸ“… 1988 πŸ› Springer US 🌐 English βš– 453 KB

Forty adults with recurring brain gliomas were treated with HECNU 130 mg/m 2, given i.v. every 5 to 6 weeks (mean 5.4) and corticosteroids. According to the response to treatment, patients were divided in 3 groups: 1. Group I included 8 pts (20%) with objective remission, defined as a clear-cut clin

Phase II trial of irinotecan plus celeco
Phase II trial of irinotecan plus celecoxib in adults with recurrent malignant glioma
✍ David A. Reardon; Jennifer A. Quinn; James Vredenburgh; Jeremy N. Rich; Sridhara πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 219 KB

## Abstract ## BACKGROUND In the current study, the authors report a Phase II trial of irinotecan (CPT‐11), a topoisomerase I inhibitor active against malignant glioma (MG), with celecoxib, a selective COX‐2 inhibitor, among MG patients with recurrent disease. ## METHODS Patients with MG at any

Phase II study of tiazofurin (NSC 286193
Phase II study of tiazofurin (NSC 286193) in the treatment of advanced small cell bronchogenic carcinoma
✍ Paul Y. Holoye; David T. Carr; Hari M. Dhingra; Bonnie S. Glisson; Jin S. Lee; W πŸ“‚ Article πŸ“… 1988 πŸ› Springer US 🌐 English βš– 115 KB

Fourteen evaluable patients with small cell bronchogenic carcinoma received tiazofurin, an inhibitor of inosine monophosphate dehydrogenase, that progressed after one combination chemotherapy. No objective remission was observed at the dosage of 800 mg/m2 for 5 consecutive days. Toxicity was moderat